Please login to the form below

Not currently logged in
Email:
Password:

Biogen’s corporate affairs SVP joins Sanofi

Kathleen Tregoning becomes executive vice president, external affairs

Sanofi Kathleen TregoningSanofi has appointed Kathleen Tregoning as executive vice president for external affairs.

Tregoning will join the Paris, France headquartered company from 27 February, when she will take responsibility for its market access, public affairs, government affairs, corporate communications, global policy and corporate social responsibility operations.

She brings over 20 years of policy, advocacy, stakeholder outreach and external engagement experience to the role, most recently from Biogen where she was senior vice president of corporate affairs.

Prior to this, Tregoning was vice president of Biogen's public policy and government affairs, having moved to the biotech in 2006 from her healthcare policy position in the United States Senate and United States House of Representatives.

Olivier Brandicourt, chief executive at Sanofi, said: “Kathleen brings a unique set of talents and experience to Sanofi that combines a deep political and policy expertise with highly relevant corporate experience in the biopharmaceutical industry.

"Working closely with the entire executive leadership team, Kathleen will lead our efforts to drive a better understanding of the value of our innovations among external stakeholders and ensure appropriate market access for our various healthcare offerings.”

30th January 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...